BioSpace News Archive

We interviewed Dr. Jo Viney, Co-Founder, President, and CSO of Pandion Therapeutics. Dr. Viney discussed her experience working within large organizations and ultimately starting her own company.

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces that is has won Start-Up of the Year in the 2019 Medilink East Midlands Business Awards.

The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.

Promore Pharma AB announce that all patients in the company’s Phase IIb-study with LL-37 for treatment of venous leg ulcers have been recruited.

Oxford Gene Technology, A Sysmex Group Company, has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

A new model in the Sona microscopy cameras range – The World’s Most Sensitive Back-illuminated sCMOS Cameras

Sanofi believes that sutimlimab, a novel investigational C1s inhibitor, has the potential to be the first approved treatment for cold agglutinin disease, a serious and chronic rare blood disorder.

Companies from across the globe provide updates to their business and pipelines.

The Dutch company Xenikos B.V., which develops innovative immunotherapies for treating patients with severe immune disease and post-transplant rejection, reports data from an expanded access program using T-Guard to treat steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.

Data on 52 patients in the 145-patient clinical trial highlight ADCT-402 (loncastuximab tesirine) continues to demonstrate anti-tumor activity and manageable toxicity in heavily pretreated patients